Pentachloronaphthalene
|
CAS
1321-64-8
|
C10H3Cl5
|
RTECS
QK0300000
|
Synonyms & Trade Names
Halowax® 1013; 1,2,3,4,5-Pentachloronaphthalene
|
DOT ID & Guide
|
Exposure
Limits
|
NIOSH REL: TWA 0.5 mg/m3 [skin]
|
|
OSHA PEL: TWA 0.5 mg/m3 [skin]
|
IDLH
Unknown
See: 1321648
|
Conversion
|
Physical Description
Pale-yellow or white solid or powder with an aromatic odor.
|
MW: 300.4
|
BP: 636°F
|
MLT: 248°F
|
Sol: Insoluble
|
VP: <1 mmHg
|
IP: ?
|
|
Sp.Gr: 1.67
|
Fl.P: NA
|
UEL: NA
|
LEL: NA
|
|
|
Noncombustible Solid
|
Incompatibilities & Reactivities
Strong oxidizers
|
Measurement Methods
NIOSH S96 (II-2)
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet or contaminated
Change: Daily
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap promptly/molten flush immediately
Breathing: Respiratory support
Swallow: Medical Attention immediately
|
Respirator Recommendations (See Appendix F)
NIOSH/OSHA
Up to 5 mg/m3:
(APF = 10) Any supplied-air respirator*
(APF = 50) Any self-contained breathing apparatus with a full facepiece
Emergency or planned entry into unknown concentrations or IDLH conditions:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Headache, lassitude (weakness, exhaustion), dizziness, anorexia; pruritus, acne-form skin eruptions; jaundice, liver necrosis
|
Target Organs
Skin, liver, central nervous system
|
|
See also: INTRODUCTION
See ICSC CARD: 0935 See MEDICAL TESTS: 0177
|
